About
Compounding Kits
Areas of Focus
Categories
Generic DrugBoston & New England
Team (9)
Amit Patel
Executive Chairman
Azurity Pharmaceuticals
board_chair
Dave Ritchie
Board Member
Azurity Pharmaceuticals
team_member
Frank Leo
Board Member
Azurity Pharmaceuticals
team_member
Jeff Edwards
Board Member
Azurity Pharmaceuticals
team_member
Mike Beckloff
QHP Capital Strategic Advisor / Former Azurity Chief Development Officer
Azurity Pharmaceuticals
advisor
Nailesh Bhatt
Board Member
Azurity Pharmaceuticals
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
290
By Phase
PHASE4: 1NA: 1
By Status
NOT_YET_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06534502Lead Sponsor
Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures
PHASE4Not yet recruiting
40 participants
Started: Dec 31, 2025 · Completed: Sep 30, 2026
NCT03597152Lead Sponsor
Nutritional Supplementation for Recurrent Urinary Tract Infections in Women
NAUnknown
250 participants
Started: Aug 1, 2020 · Completed: Dec 31, 2022
Locations (1)
Headquarters
Wilmington, MA, United States
Map
Loading map...